Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery

On behalf of the N3C Consortium

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations
Original languageEnglish (US)
JournalAnnals of surgical oncology
DOIs
StateAccepted/In press - 2022

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this